{"id":"W4211142045","doi":"10.1016/j.kint.2018.12.025","title":"Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","year":2019,"lang":"en","type":"article","venue":"Kidney International","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"ca_institutions":"NOSM University; University of Toronto","funders":"Relypsa; Janssen Research and Development; National Institutes of Health; Akebia Therapeutics; Servier; Novo Nordisk; FibroGen; Bayer HealthCare; Sanofi; European Commission; National Institute of Diabetes and Digestive and Kidney Diseases; Amgen; Vifor Pharma; Pfizer; GlaxoSmithKline; Satellite Healthcare; Fresenius Medical Care North America; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Guideline; Kidney disease; Medicine; Intensive care medicine; Blood pressure; Dialysis; Multidisciplinary approach; Clinical Practice; Disease; Clinical trial; Internal medicine; Physical therapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001219165,0.0003851765,0.0007612043,0.0001331148,0.0001230997,0.000100073,0.0004206057,0.0001324823,0.004565478],"category_scores_gemma":[0.002884689,0.0003277051,0.0002723036,0.0001428817,0.0001532074,0.0003138564,0.0005366956,0.0003382276,0.0002271869],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001124895,"about_ca_system_score_gemma":0.002580233,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007704043,"about_ca_topic_score_gemma":0.00004554351,"domain_scores_codex":[0.9973783,0.00006919599,0.0005005997,0.0007237408,0.000874093,0.0004540081],"domain_scores_gemma":[0.9969221,0.0002389323,0.000188879,0.0005665822,0.000399194,0.001684259],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007609167,0.0005268426,0.7639251,0.0002356726,0.003353523,0.0002853022,0.0002218169,0.00001233543,0.003213248,0.005028634,0.2221328,0.0003037483],"study_design_scores_gemma":[0.01392714,0.0001196804,0.3865011,0.00119734,0.00425629,0.00001344659,0.0001458554,0.004320861,0.000160905,0.0009165871,0.5879125,0.0005283228],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.240707,0.03814635,0.0004298938,0.5833857,0.01352719,0.005891711,0.06195379,0.001094843,0.05486357],"genre_scores_gemma":[0.9496542,0.000197458,0.0002277384,0.04005845,0.0005256271,0.00007140282,0.001405232,0.00002965497,0.007830229],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.7089472,"threshold_uncertainty_score":0.9999175,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01341825457803769,"score_gpt":0.2721447551330451,"score_spread":0.2587265005550075,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}